Is there momentum behind the Dechra Pharmaceuticals share price?

Is there momentum behind the Dechra Pharmaceuticals share price?

Article image

It has been a wild ride for some of the UK's biggest quoted companies over the past year. Economic uncertainty persists and the question on the minds of many investors is where the prices of stocks like Dechra Pharmaceuticals (LON:DPH) will go from here.

Dechra Pharmaceuticals is one of a surprisingly small number of special shares on the London Stock Exchange that have market valuations in excess of £1 billion. The stock currently has a market capitalisation of £4,117m

These large-cap shares are closely watched because they have an important influence on the investment funds and pension portfolios of millions of savers. So amid the uncertainty, how has the stock fared?

Over the past 12 months, the Dechra Pharmaceuticals share price has seen an absolute move of -2.01%. On a relative basis - which take into account the movement of the wider market - the shares have moved by -8.97% over the past year and by -27.5% over the past six months.

But what now?

Do analysts rate it as a buy, sell or hold?

Regardless of recent performance, the main question for investors is what the future holds. In uncertain economic conditions, it's often difficult to get an accurate view. The good news is that analysts generally understand the market's biggest businesses better than most, so they are well-placed to make predictions. That shows up in their Buy, Hold and Sell recommendations.

Among the analysts covering Dechra Pharmaceuticals, there are currently:

  • 2 Buy recommendations
  • 5 Hold recommendations
  • 0 Sell recommendations

With this kind of information, it's possible to start forming a view about the outlook for any share. A combination of recent price performance and analyst recommendations gives you a flavour of whether the market is expecting a bright future - or whether there are causes for concern.


What does this mean for potential investors?

Dechra Pharmaceuticals is one of the most closely watched shares in the market. But while price trends and broker recommendations can give you an idea about the sentiment around a stock, they can't tell you everything. 

To get a better understanding of the overall investment case, it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Dechra Pharmaceuticals that you can find out about here.


About us

Stockopedia helps individual investors make confident, profitable choices in the stock market. Our StockRank and factor investing toolbox unlocks institutional-quality insights into thousands of global stocks. Voted “Best Investment Research Tools” and “Best Research Service” at the 2021 UK Investor Magazine awards.

As per our Terms of Use, Stockopedia is a financial news & data site, discussion forum and content aggregator. Our site should be used for educational & informational purposes only. We do not provide investment advice, recommendations or views as to whether an investment or strategy is suited to the investment needs of a specific individual. You should make your own decisions and seek independent professional advice before doing so. Remember: Shares can go down as well as up. Past performance is not a guide to future performance & investors may not get back the amount invested.